Francesca Ambrosi

17PUBLICATIONS
57CO-AUTHORS
Predictive and prognostic markersMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Haematological tumoursSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Mar 19, 2026
Mucosal melanoma of the head and neck region: clinical-pathologic implications of tumor microenvironment evaluated with multiplex immunohistochemistry.

Costantino Ricci, Barbara Corti, Ernesto Pasquini

|Jan 20, 2026
New insights into Nectin-4 expression in testicular choriocarcinoma and its potential treatment with Enfortumab Vedotin: analysis of a multi-institutional series and association with clinical-pathological features.

Costantino Ricci, Luisa Di Sciascio, Francesca Ambrosi

|Sep 19, 2025
Immunohistochemical expression of EZH2 in germ cell tumors of the testis: New insights into the genesis and epigenetic reprogramming of these fascinating tumors.

Sofia Melotti, Francesca Ambrosi, Tania Franceschini

|Sep 11, 2025
Immunohistochemical expression of Nectin-4 and potential implications for enfortumab vedotin therapy in germ cell tumors of the testis: a preliminary study.

Costantino Ricci, Francesca Ambrosi, Tania Franceschini

|Sep 05, 2025
Correction to: The absence of FOXA2 and HNF1β expression in vasculogenic mesenchymal lesions of germ cell origin suggests an evolutionary pathway similar to that of sarcomatoid yolk sac tumor.

Costantino Ricci, Luisa Di Sciascio, Francesca Ambrosi

|Aug 17, 2025
The absence of FOXA2 and HNF1β expression in vasculogenic mesenchymal lesions of germ cell origin suggests an evolutionary pathway similar to that of sarcomatoid yolk sac tumor.

Costantino Ricci, Luisa Di Sciascio, Francesca Ambrosi

Pageof 3

Frequent Collaborators

16 joint publications

Costantino Ricci

14 joint publications

Michelangelo Fiorentino

10 joint publications

Veronica Mollica

10 joint publications

Andres Martin Acosta